Expertise in
4
conditions

Peter Ciznar

Bratislava, BL, SK 
Expertise in
4
conditions
Bratislava, BL, SK 

Overview

Peter Ciznar practices practicing medicine in Bratislava, Slovakia.

Mr. Ciznar is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hyper IgE Syndrome, Autosomal Dominant Hyper IgE Syndrome, Primary Immunodeficiency (PID), and Nijmegen Breakage Syndrome.

He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Bratislava, BL, Slovakia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by Primary Immunodeficiency Disease (PID)
A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by Primary Immunodeficiency Disease (PID)
Enrollment Status: Active_not_recruiting
Publish Date: May 29, 2026
Intervention Type: Biological
Study Phase: Phase 3
Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric Subjects With Primary Immunodeficiency Diseases
Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric Subjects With Primary Immunodeficiency Diseases
Enrollment Status: Completed
Publish Date: January 11, 2023
Intervention Type: Biological
Study Phase: Phase 4
View 1 Less Clinical Trial

29 Total Publications

Impact of 22q11.2 deletion syndrome on clinical and immunological status of infants with conotruncal heart defects.
Impact of 22q11.2 deletion syndrome on clinical and immunological status of infants with conotruncal heart defects.
Journal: Cardiology in the young
Published: January 22, 2026

Frequently Asked Questions about Peter Ciznar

Is Peter Ciznar a top-rated expert for Hyper IgE Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Peter Ciznar is classified as an Distinguished expert for Hyper IgE Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter Ciznar participate in research or clinical trials?

Yes. Peter Ciznar has published 29 articles and abstracts on conditions like Hyper IgE Syndrome. You can view a list of Peter Ciznar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ciznar's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile